According to BioXcel Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ5.47. In 2022 the company made an earnings per share (EPS) of -ยฃ4.54 a decrease over its 2021 EPS that were of -ยฃ3.14.